Cbay stock forecast.

CymaBay Therapeutics (CBAY) Stock Forecast & Price Target $17.90 -0.21 (-1.16%) (As of 11/22/2023 ET) Compare Share Today's Range $17.82 $18.45 50-Day …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Coterra Energy share forecasts, stock quote and buy / sell signals below. According to present data Coterra Energy's CTRA shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Spruce Biosciences Inc have a median target of 8.50, with a high estimate of 10.00 and a low estimate of 7.00. The median ...Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.See CymaBay Therapeutics, Inc. (CBAY) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.

CBAY enters Uptrend as Momentum indicator ascends above 0 level This indicator may be signaling that CBAY's price has momentum to move higher, since its current price …

The consensus price target of analysts on Wall Street is $24.42, which implies an increase of 21.66% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $20.00 and $34.00 respectively. As a result, CBAY is trading at a discount of -77.73% off the target high and -4.55% off the low.Find the latest CymaBay Therapeutics Inc. CBAY analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. investment rating.

Stock Price Forecast The 9 analysts offering 12-month price forecasts for Blink Charging Co have a median target of 5.00, with a high estimate of 25.00 and a low estimate of 3.00.Jun 30, 2023 · CBAY Stock Forecast: Positive Outlook and Analyst Consensus for CymaBay Therapeutics Inc. CBAY stock has been performing well in recent months, with positive forecasts from analysts. On June 30, 2023, the 10 analysts offering 12-month price forecasts for CBAY had a median target of $15.00, indicating a potential increase of 35.14% from the last ... Based on 6 Wall Street analysts offering 12 month price targets for Aldeyra Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $11.00 and a low forecast of $8.00. The average price target represents a 352.49% change from the last price of $2.21. Highest Price Target $11.00. Average Price Target $10.00.Nov 3, 2023 · Cymabay Therapeutics Inc (NASDAQ:CBAY) trade information. Cymabay Therapeutics Inc (CBAY) has traded red over the past five days. The stock hit a weekly high of 16.87 this Thursday, 11/02/23. The 5-day price performance for the stock is 8.04%, and 17.06% over 30 days. With these gigs, the year-to-date price performance is 161.56%.

Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when CymaBay Therapeutics, Inc. stock was issued.

Interactive Chart for CymaBay Therapeutics, Inc. (CBAY), analyze all the data with a huge range of indicators.

PTC Therapeutics Inc. -3.71%. $1.57B. CBAY | Complete CymaBay Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The Cidara Therapeutics stock price fell by -0.699% on the last day (Friday, 24th Nov 2023) from $0.715 to $0.710. It has now fallen 5 days in a row. During the last trading day the stock fluctuated 10.03% from a day low at $0.698 to a day high of $0.768. The price has fallen in 6 of the last 10 days and is down by -5.71% for this period.Xenon Pharmaceuticals Inc. 28.97. +0.24. +0.84%. Get CymaBay Therapeutics Inc (CBAY:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. CymaBay Therapeutics, Inc. (CBAY) share price prediction for 2023, 2024, 2025, 2026 and 2027. CBAY one year forecast. Cymabay Therapeutics stock monthly and weekly ...

NEWARK, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical company focused on innovative therapies for patients with liver and other chronic ...Based on 6 Wall Street analysts offering 12 month price targets for Aldeyra Therapeutics in the last 3 months. The average price target is $10.00 with a high forecast of $11.00 and a low forecast of $8.00. The average price target represents a 352.49% change from the last price of $2.21. Highest Price Target $11.00. Average Price Target $10.00.CymaBay Therapeutics Inc. $19.71. CBAY 3.03%. ImmunoGen, Inc. $29.32. IMGN 0.10%. MoonLake Immunotherapeutics. $46.10. MLTX 4.99%. PTC Therapeutics, Inc. $23.99.Predicting the weather has long been one of life’s great mysteries — at least for regular folks. Over the years, you’ve probably encountered a few older adults — maybe even your own grandparents — who made some weather predictions based on ...Cymabay Therapeutics Inc Stock Price Forecast, "CBAY" Predictons for2025CBAY Stock Forecast: Positive Outlook and Analyst Consensus for CymaBay Therapeutics Inc. CBAY stock has been performing well in recent months, with positive forecasts from analysts. On June 30, 2023, the 10 analysts offering 12-month price forecasts for CBAY had a median target of $15.00, indicating a potential increase of …According to the issued ratings of 7 analysts in the last year, the consensus rating for Verastem stock is Buy based on the current 7 buy ratings for VSTM. The average twelve-month price prediction for Verastem is $29.71 with a high price target of $36.00 and a low price target of $21.00. Learn more on VSTM's analyst rating history.

Find the latest CymaBay Therapeutics, Inc. (CBAY) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Cymabay Therapeutics Stock Chart and Share Price Forecast, Short-Term "CBAY" Stock Prediction for Next Days and Weeks Walletinvestor.com Cymabay Therapeutics Inc (CBAY) Forecast Chart, Long-Term Predictions for Next Months and Year: 2023, 2024

CymaBay Therapeutics Inc. (CBAY) stock forecast and price target. Find the latest CymaBay Therapeutics Inc. CBAY analyst stock forecast, price target, and recommendation trends with in-depth ... CBAY one year fore… Wednesday, November 23, 2022 Edit. emporia hotels in marriott. marriott hotels in emporia va. Quality Inn Emporia November 23, 2022 Edit. Jill Scott wallpaper. ... cbay stock forecast cnn. Based on 5 Wall Street analysts offering 12 month price targets for CymaBay Therapeutics in the last 3 months. CBAY one year …Stock Price Forecast. The 6 analysts offering 12-month price forecasts for Digital Turbine Inc have a median target of 5.50, with a high estimate of 12.00 and a low estimate of 5.00. The median ...The current CymaBay Therapeutics [ CBAY] share price is $17.90. The Score for CBAY is 74, which is 48% above its historic median score of 50, and infers lower risk than normal. CBAY is currently trading in the 70-80% percentile range relative to its …Wall Street Stock Market & Finance report, prediction for the future: You'll find the CBAK Energy Technology share forecasts, stock quote and buy / sell signals below. According to present data CBAK Energy Technology's CBAT shares and potentially its market environment have been in bearish cycle last 12 months (if exists).Village Farms International Inc () Stock Market info Recommendations: Buy or sell Village Farms International stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Village Farms International share forecasts, stock quote and buy / sell signals below.According to present data Village Farms International's VFF shares and …The stock is selling for $9.87 and its $13.89 average price target suggests a 12-month upside potential of ~41%. (See CBAY stock forecast ) Cerevel Therapeutics ( CERE )

CymaBay Therapeutics Stock Forecast 2023. In the last five quarters, CymaBay Therapeutics’s Price Target has fallen from $29.28 to $23.09 - a -21.14% decrease. Five analysts predict that CymaBay Therapeutics’s share price will fall in the coming year, reaching $10.00. This would represent a decrease of -56.69%.

In a recent transaction on November 17, 2023, Charles Mcwherter, the President of Research and Development at CymaBay Therapeutics Inc (NASDAQ:CBAY), sold 11,342 shares of the company's stock ...

Reported on 11/6/23. Get the latest CymaBay Therapeutics Inc (CBAY) real-time quote, historical performance, charts, and other financial information to help you make more …All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...Investors often compare top stocks against the Russell 3000 Index, a broad measure of the U.S. stock market comprising 3,000 large publicly traded companies or 96% of the investable U.S. equity ...Discover historical prices for CBAY stock on Yahoo Finance. View daily, weekly or monthly format back to when CymaBay Therapeutics, Inc. stock was issued. (See CBAY stock forecast on TipRanks) AbSci Corporation . For the second penny stock we’ll look at, we’ll stick with the medical tech field – but look at a company with a different take on ...All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...EBAY Regular Dividend: EBAY will begin trading ex-dividend today with a $0.25 dividend payable to shareholders of record as of 12/01/23. Quote. Profile. News. Charts. Forecasts. Financials ...Dec 1, 2023 · CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company's lead ... He kept his outperform rating on CBAY stock and raised his price target to 20 from 18. Notably, CymaBay stock has a best-possible Relative Strength Rating of 99, according to IBD Digital. This ...

Shares of CymaBay Therapeutics ( CBAY -1.16%) were jumping 14.2% higher as of 10:54 a.m. ET on Friday. This move came on the heels of an 8.5% gain on Thursday. The continued momentum is a result ...Dec 1, 2023 · CymaBay Therapeutics (CBAY) Stock Price, News & Analysis $17.90 -0.21 (-1.16%) (As of 11/22/2023 ET) Compare Today's Range $17.82 $18.45 50-Day Range $12.63 $18.66 52-Week Range $3.21 $19.06 Volume 1.15 million shs Average Volume 1.89 million shs Market Capitalization $2.03 billion P/E Ratio N/A Dividend Yield N/A Price Target $22.27 TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.comInstagram:https://instagram. most rare state quarterswill cds go upcbocs front porchare semiconductor etfs a good investment Last month, Menold Daniel, the VP Finance of CBAY bought 15,500.00 shares for a total of $79,010.00. TipRanks has tracked 36,000 company insiders and found that a few of them are better than ...Analyst projections state that BYND is forecast to be at a low of $3.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -39.32% from its current level, while the stock would need to crash 53.56% from its current level to reach the projected low. Beyond Meat Inc (BYND) estimates and ... nasdaq dkng comparefinancial planner ri CBAY Signals & Forecast. Mostly positive signals in the chart today. The Cymabay Therapeutics Inc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average.Analyst projections state that BYND is forecast to be at a low of $3.00 and a high of $9.00. In order for the stock price to hit the forecast high, the stock would need to plunge -39.32% from its current level, while the stock would need to crash 53.56% from its current level to reach the projected low. Beyond Meat Inc (BYND) estimates and ... best volume indicators Stock analysis for Cymabay Therapeutics Inc (CBAY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.5 brokers have issued 12-month price targets for X4 Pharmaceuticals' stock. Their XFOR share price targets range from $3.00 to $5.00. On average, they anticipate the company's share price to reach $3.50 in the next year. This suggests a possible upside of 359.6% from the stock's current price.